About your Search

20130101
20130131
STATION
CNBC 42
FBC 12
SFGTV 11
WBAL (NBC) 11
CSPAN2 6
WRC 4
KICU 3
KNTV (NBC) 3
KRON (MyNetworkTV) 3
KGO (ABC) 2
KQED (PBS) 2
MSNBCW 2
WETA 2
WJZ (CBS) 2
CNN 1
CNNW 1
( more )
LANGUAGE
English 116
Search Results 0 to 49 of about 116 (some duplicates have been removed)
pfizer is using new strategies to protector lipitor and beat back the generics. - why are these deals secret and why is it they aren't in the light of day? - about 75% to 80% of all u.s. prescriptions today are for generics. - if it's generic and i still have to use the regular lipitor, it doesn't seem fair for me to have to pay that full price. - also inside e street, the gps shoe, the latest tool to locate wandering loved ones. - not only can we track them with the push of a button, we can also set a safety perimeter, say 100 yards in any direction around their house. - "inside e street" is made possible by... - auto and home insurance fr auto and home insurance from t he hartford . more than 200 years of helping to protect what's most important. for information about our program for drivers 50 and over, including how to find an agent visit hartfordautoinsurance.com - from the heart of the nation's capital and around the country you're inside e street with lark mccarthy. - if you look in your medicine cabinet, chances are good you have at least one of
. >>> coming up -- animal spirits? pharmaceutical giant pfizer will complete the spinoff of the animal health unit with an ipo next week. is this business the cat's meow, or is the stock setting up to be a real dog? cramer keeps your portfolio out of the pound in this edition of "know your ipo." >>> and later, all aboard. the markets may be making new highs, but if you want your portfolio on the fast track, it takes more than following the leader. tonight, cramer's eyeing up the stocks that could be ready to pull away from the pack, all coming up on "mad money." don't miss a second of "mad money." follow @jimcramer on twitter. have a question? tweet cramer, #madtweets. send jim an e-mail to madmoney@cnbc.com, or give us a call at 1-800-743-cnbc. miss something? head to madmoney.cnbc.com. >>> pfizer, one of my absolute favorite big pharma companies with a fabulous pipeline, 3.6% yield is now in full-on breakup mode, and as regular viewers of this show are quite aware, we can't get enough of these breakups here on "mad money." in fact, the idea of splitting up your company in order to instantly
with tim collins and my colleague at thestreet.com. and what he says is the best chart out there. pfizer. the big pharma company that has been doing a lot of good things. bringing out value. he said it reminds him of monsanto. back when he loved what he saw on the chart on july 23rd. man what i call. since then the stock has been roaring. collins nailed this one. it is also not like the companies that seem to have regular meaningful breakthroughs. those are science factories that seem to do nothing but produce amazing drugs that go down in what seems like 60 seconds. pretty solid company. when he looks at the daily chart he sees some things that makes him think that phizer could be ready to run. they are trying to a certain things that seem to make it over and over again into an up stock or down stock and pfizer has made the bullish pattern one that collins is very excited. it has made an inverse head and shoulders formation. it is called that because it looks like an upside down head between two shoulders. not at all because it can be an upside down bottle of shampoo that are shaped lik
healthy numbers from pfizer. very close to 14,000. the last hour of trading, "countdown to the closing bell" begins right now. the dow closing at the best level since october 2007. quickly approaching a well-rounded 14,000 level everybody looks at and it is just about 1.5% away from that all-time high. perhaps tomorrow's fed decision will be the catalyst or it will blow everything apart. look at the winners and pfizer up more than 3% looking very healthy, $0.87 gain. why pfizer? they're reporting better-than-expected quarterly earnings. pfizer back to 2013 forecast, analysts love this and you can see merck right behind it. pfizer and procter & gamble are rising along with eli lilly trading at record highs which is significant because a lot of people question health care. we will talk about that in just a minute. where else is the money flowing today? look no further than the homebuilders. up 11%. q4 earnings beat the street by a wide margin. new orders jumping 39% right behind us, 1.44. for underway the real winner. folks, if you ask the same questions a lot wants to ask, pay particula
if you ask me. and an oil and gas kicker could be rebounding because of china. pfizer was up 15% last year and i think that not only can they repeat that performance but best it as the giant company takes action to bring up value with its animal health business and does its best to return capital via an even higher dividend that yields 3.75%. i like the paint drying pfizer. it lets you sleep at night and by day, too. i don't know in walmart can repeat its gains of more than twice the returns from the dow. the consumer market is a little weakened. 3m up 13%, united technologies up 12%. they are naturals to repeat their gains if not do better, given their strong asian exposure. 3m has been held back by a weak china. they can only improve from here after that tax bill. two well-run companies, perfect proxies for worldwide growth. at&t 11% gains, even the most boring of stocks can generate double digit returns. i think the same gain is in the cards for this year. cisco, for all its flaws, still beat the dow by a percentage point. i can't see this company returning to the days of yore, tha
of disruption. pfizer is the news of breakup speculation. if you're shopping for a drug stock, which is the better buy, j&j or pfizer? talking numbers on both sides. technical side of the story ennis tanner is with riskreversal.com and on the fundamentals steve cortes is founder of veracruz and a cnbc contributor. kick us off with fundamentals, steve, how are the companies doing? >> i like both companies and like the entire space but i do prefer johnson & johnson. if there's something that we can count on right now in america, as a country we're getting both older and we are getting fatter and johnson & johnson frankly is one of the best ways that i can think of to play with both of those macro trends. the older part i want to be in pharmaceuticals generically because i want to be involved in a demographic upswing and inters of the obesity side, johnson & johnson, why i prefer it to be-to-pfizer, and why johnson & johnson has an advantage when it comes to type ii diabetes. they are further along and in the best position of any farm sewell suit call company to release a serious drug a
investor is pushing for even more spin-offs at hess. drug maker pfizer helped the health care sector move up today even as it continues to see sales hurt by generic drug competition. pfizer earned 47 cents per share. while down from a year ago, it was a better result than what was expected. generic versions of its cholesterol-lowering drug lipitor continued to pressure overall sales. but traders and investors were encouraged that pfizer's pipeline of new medicines will help expand sales in the quarters to come. shares gained 3.2% to close at a new 52-week high. the buying. though, comes ahead of pfizer's spin off of part of its animal health unit. that initial stock sale is expected to come on friday. fellow drug company eli lilly rallied 3.2%, also at a new 52- week high. its results also were stronger than anticipated. lilly, though, increased its 2013 forecast while announcing it will buy back $1.5 billion of its own stock. but it was a cautious outlook for data storage giant e.m.c. that hit its shares today. the stock fell 4%. volume exploded to more than six times normal. it was the
and production. an activist investor is pushing for even more spin-offs at hess. drug maker pfizer helped the health care sector move up today even as it continues to see sales hurt by generic drug competition. pfizer earned 47 cents per share. while down from a year ago, it was a better result than what was expected. generic versions of its cholesterol-lowering drug lipitor continued to pressure overall sales. but traders and investors were encouraged that pfizer's pipeline of new medicines will help expand sales in the quarters to come. shares gained 3.2% to close at a new 52-week high. the buying. though, comes ahead of pfizer's spin off of part of its animal health unit. that initial stock sale is expected to come on friday. fellow drug company eli lilly rallied 3.2%, also at a new 52- week high. its results also were stronger than anticipated. lilly, though, increased its 2013 forecast while announcing it will buy back $1.5 billion of its own stock. but it was a cautious outlook for data storage giant e.m.c. that hit its shares today. the stock fell 4%. volume exploded to more than s
, here, let's make things easy. some things in life are easy and one of them is pfizer. yeah, pfizer. we know pfizer's breaking up and we think that pfizer's breaking out. not like the breakout i'm having right now. too much makeup. i was not all day today because of that acme thing. i can tell i was breaking out. it's more of a chart term i'm using here. don't forget it's spinning out its animal health business which ipos in a week. i want you in on that deal. a lot of pfizer action. pfizer the common. i like pfizer spinoff. just take it from me that that's going to be -- if that stock comes down, buy buy buy. after the close tuesday, really tough, amazon reports. here's a stock has been charmed. the stock with the midas touch. hitting still one more anti-high today. it's the anti-apple. it seems no matter what amazon says everyone laps it up now. no winkies no, flying monkeys on that call but only after the stock initially gets hammered. i want you to trigger, not before then. if it takes off, it's going to be too difficult to chase. i don't want you to do that. but be aware that there
of information. some things in life are easy and one of them is pfizer. yeah, pfizer. we know pfizer is breaking up and we think that pfizer is breaking out. not like the breakout i'm having right now. too much makeup. i was on all day today because of that ackman thing. i could tell that i was breaking out. it's spinning out its annual health business and i want you in on that deal. so a lot of pfizer action here. i like phase thor the common, i like pfizer the spin-off. take it from me, if that stock comes, buy, buy, buy. after the close tuesday, really tough amazon reports. this stock with the midas touch. it's the anti-apple. it seems no matter what amazon says, everyone laughs it up now. no winkies, no flying monkey owes that call. but only after the stock initially gets hammered. i want you to pull the trigger, not before then. if it takes off, it's going to be too difficult to chase. be aware there is a distinct pattern here on amazon. the news comes out, morons sell it because they think it doesn't look good. the stock plummets. they know we go through it, slowly but surely. it's like, y
and outreach, traditional and digital media will report to you. miss su comes to us from pfizer in new york city where she served as director of branded marketing and communications. i don't know what it is, but it sounds complicated. prior to pfizer she worked at warner lambert and chase manhattan bank in various management positions. thank you on behalf of all of my colleagues and welcome on board. >> congratulations and welcome, miss su. >> thank you. well, mr. chairman and members of the board, it's wonderful to have the opportunity to return to the city of my birth. san francisco. after 25 years of being away on the east coast. and i am truly honored to have this opportunity to return and serve the people of san francisco by serving in the role of communications director at sfmta. so i'm looking forward to working with you and the sfmta staff and the people of this great city to ensure that we have great and wonderful choices available to all people here. >> thank yous miss su and welcome. glad you are here. miss jean baptiste. >> good afternoon chairman and members of the board.
will report to you. miss su comes to us from pfizer in new york city where she served as director of branded marketing and communications. i don't know what it is, but it sounds complicated. prior to pfizer she worked at
. >> thanks for having me. lori: pfizer and little lilly lost a hefty sum. do you expect them to rebound this year? >> i think so. we're approaching an inflection point for the pharmaceutical industry. we're moving away from patent losses and moving towards pipelines that are getting better, much better pipelines than we've seen in the last five years. that should really entice the investment community to look at these stocks where they have been trading flat for many, many years. finally over the last few months, started to get a little bit of momentum. lori: let's go in this direction. ther pipeline, better innovations but a much tougher fda, right? will that curb getting new products to market? >> you know it could. what happened is if you look at the past few years the fda got very conservative in response to the vie yox recall and avandia scares. high-profile drugs that got recalled so the fda got very conservative. what the pharmaceutical companies have done focus in unmet medical needs in oncology and neurology and immunology. if these areas if you show a little bit of efficacy yo
with a high surf and pfizer expectehigh surf revisory. right the beaches, the high surf advisory. the waves can catch you off guard and a strong rip current. and speaker waves. again, this is a dangerous situation. right now,--snekaer ...waves.. could catch you off guard if you are in the water or at the shore. 20's and 30's by the bay. that fog in the north bay, and also, as patchy fog put a limit visibility. here is a cool start but warm in the afternoon. 60s and the repeat performance on martin luther king day. sunny and the 60s. the satellite with clear skies and these storms are typically out there are over the pacific but they are going to try to go this way. and the progress towards the west coast will change by wednesday. we will see clouds increasing and the possibility for some rainfall late wednesday in the event thursday. for tomorrow, sunshine and look at these temperatures. 60s through santa clara 65 degrees and sunny, mild for the inland areas. with low mid 60s for the bayshore. the north bay valleys will also cease 60s 65 degrees in napa, san francisco. and a cemetery, oakla
is moving closer to the $14 and dollar mark. drug maker pfizer, one of the dow's 30 stocks helped with the search with help from a drug maker pfizer, the dollar is moving closer to 14,000. the s&p 500 gained eight points, while the nasdaq fell less than a point. watching research in motion. along a delay of blackberry attend lunches today. is it too little too late? or will this did research in motion back in the gang. reviewers like the browser split speed and the keyboard on rims and you touch screen. a feature called the black berry balance, which keeps corporate and personal data separate. where am stock was at 144 a share in 2008. if now is trading around 15 bucks a share. >> u.s. transport safety regulators have asked boeing to provide a full operating history of the lithium-ion batteries that were used in its 787 dream liner is. then end-t-s-be made the request after becoming aware of battery incidents that occurred before january the seventh. battery fire in a 787 park at a boston logan international airport. all nippon airways says that it has replaced the batteries on is
for a slight downtick from december. we'll hear from eli lilly and pfizer. dr horton, a home builder, emc, harley davidson and jet blue and after the close we'll hear from amazon. so a busy day both in terms of earnings and data. a busy week, in fact, we'll hear from the fed tomorrow, the jobs report friday. gdp tomorrow. i'm all excited. >> today -- the close yesterday, i don't know on, yesterday was pretty directionus when we closed. >> it was amazing to see that cnbc index. we don't usually see that. it's been very quiet in markets despite all of those major events. you wonder whether people are positioned to move open. >> we've had this big run, a little breather. we've got the fed coming up, as well. they've got the two-day policy meeting today with a decision due tomorrow at 2:15 eastern. the fed widely expected to hold firm, sticking to its low rate message. last month, the central bank figured it would stop tying policy to specific economic target. the fed said as long as inflation stays subdued, rates could remain another historic lows until unemployment dips at 6.5%, which they
about that. let's go back to nicole petallides. pfizer shares are on the move. nicole: that is right. this is a stock that everyone has been focused on. they have faced intense generic competition for lipitor. they have seen sales drop in that particular area. pfizer up 3.2% right now. they have a pending sales of a nutrition unit. that is something certainly giving them a boost. they're pain drugs, they also have a sizable market for river toward arthritis. this is why they are doing well. buybacks have been very shareholder friendly over 52 weeks. and spending cuts is something else that pfizer has been working on. how is the dow doing right now. of about 52 points right now. hello, we are at the height of the day. 13,944. connell: getting close. thank you. president obama getting set to unveil his plan for immigration reform. he will have that later in the day from las vegas. haley barbour joins us now. the politics of this have been really talked about a lot. in fact, we talked about it earlier this hour. let me start with the economics of immigration reform. a number of ceos hav
are at 13,945. pfizer pushing us ever closer to a new time high despite an unexpectedly weak reading on consumer confidence. melissa: the new push to turn a tiny island off detroit into a free market utopia. i love this story. lori: let's go to pack your bags, folks. lou dobbs here with us. an agreement that lays down a path to citizenship for 11 million illegal immigrants in this country. let's head to the floor of the new york stock exchange. the dow pushing session highs right now. nicole: it certainly is. we are back touching them once again. the nasdaq composite has been one of the three industries that we have followed so closely and it has been in the red. it is down, not even two points. the s&p 500 also setting new highs here. going back to these levels that we have not seen since 2007. let's begin with ford motors. it is down about 5.5%. he talked about europe. that is something that is still plaguing them. they did say that europe still remains a problem. the outlook in the near-term is troublesome. they did see that they had and and a deep to climb in prices. back to you.
this morning, including reports from pfizer. also, ford international paper and harley davidson and that's just before the bell. the big report after the bell will be from amazon. so plenty for investors to digest today. and while that's going on, the federal reserve will kick off the first fomc meeting. now that we've got it right here. so i was right. i don't like to -- >> it is 2013. >> i don't like to challenge because i remember something. didn't cathy griffin do something, anderson cooper's -- >> you called it a sardine. i do remember, something happened. >> it takes you until about july to figure out writing the right year. >> on checks? >> yeah. >> it haven't written a check in a wild. >> i have to think long and hard before i write that out. >> it's the first federal meeting of the year. big piece in the journal today. john taylor, not the hedge fund john taylor but the former appreciatory under secretary. stanford say the says holding back the economy, the federal reserve is holding back the economy. >> steve liesman will be along at 7:30 eastern. i don't think he would buy into that.
products 5-10% above competitors such as pfizer and bayer. the nation's largest retailer is reaching out to men and women in the service. wal-mart is offering a job to every veteran who honorably left the military in the past year. the program will continue for 5 years and is expected to provide work for more than 100,000 veterans. additionally, the retailer is committing to buying an additional $50 billion of u.s.- made products in the next 10 years. the government of japan joins the u.s. government in investigating boeing's 787 dreamliner. the probe is to uncover what caused two fuel leaks on two different dreamliners operated by japan airlines. japan's transport ministry said they opened the investigation because the two fuel leaks "occurred in succession." the faa says 787s are safe, but is conducting a comprehensive review to ensure no flaws are present. an end-of-the-year surge of consumer buying gave a lift to retail sales in december. retail sales rose .5%, which was higher than economists predicted and slightly better than the .4% rise in november. much of consumer spending came
after so much loss. >>> making a difference. brought to you by pfizer. >>> time now for our "making a difference" report. more than 70 days now since hurricane sandy, still a lot of this region is in the dark with so many homes destroyed, condemned or not near ready to be lived in. that's where the volunteers from a charity group called "operation blessing" come in. you're about to see what they can do. nbc's rehema ellis has our "making a difference" report tonight from breezy point queens, part of coastal new york city. >> reporter: this breezy point neighborhood was devastated all at once by sandy. but the recovery is happening one home at a time. for three weeks, hundreds of volunteers have been working to rebuild this house for retired grandparents, jean and burt metz, who were told only the floors and walls were being rebuilt. 72 days ago, 4 feet of floodwater rushed in, leaving behind dangerous mold. how much work did you do on the house? >> we did this house from stud to completion. here is a couple, gives back to their community, two-time cancer survivor. then on top of it,
by pfizer. time for our final story of the week. and it's about one woman's really good idea sparked by a terrible stat about how much food goes to waste in this country every single day. she has enlisted an army of volunteers to help save it, and she is "making a difference" for a lot of families who need it. we get her story tonight from dr. nancy snyderman. >> it's early on a wednesday morning and this farmer's market is bustling. >> how are you doing this morning? >> brussel sprouts. >> fresh fruits and vegetables grown here in the southern valley of california. but how this food gets from the field to the dinner table might surprise you. >> we rescue produce, giving it a second life for the plates of the for. >> she is called a vegetable contained crusader. she was shocked to learn that 40% of what we grow in this country gets thrown away. bruised, damaged, even surplus crops are left to die on the vine. so she started hidden harvest, a company that rescues unwanted produce and gets it to the needest, some 60,000 low-income people every month. people like retiree, lois, who reli
the bell earnings action, we get a broad economic snapshot from ford, pfizer and ak steel. after the close, we'll see how online retail titan, amazon did after the crucial holiday shopping season. the fed begins a policy pow wow. the central bank will keep interest rates near record lows. bargain hunters scooped up apple stock after it tumbled 14% putting apple in the most valuable spot. toyota, the auto maker the world's largest auto maker thanks to a 23% surge. general motors announced spending millions to upgrade an assembly plant. meanwhile, a government watchdog is calling autothe pay czar for executive pay. companies bailed out by the government, aig and ally financial. we have heard chicken wings are more expensive this time of year. men stole $65,000 worth of tyson frozen chicken wings. straight ahead, we get the insight from lynn sweet of the chicago sun times. what lebron james said about his white house visit and the newest edition to the dog show. you are watching "first look" on msnbc. [ female announcer ] going to sleep may be easy, but when you wake up in the middle of the n
, pfizer, pharmaceuticals and a.k. steel. and we'll see if amazon weathered the crucial holiday shopping season. i know i spnt a lot. >>> also ahead today, the fed begins its first two-day powwow of the new year. speculation is the central bank will keep interest rates near record lows. >>> on the street monday, bargain hunters scooped up apple stock after it tumbled 14% last week, putting apple back into the most valuable spot ahead of exxonmobil. >>> also back on top, toyota, the automaker retook the title as the world's largest automaker thanks to a 23% surge in global sales last year. >>> general motors announced it's spending millions to upgrade an assembly plant in kansas city where it produces the chevy malibu and buick lacrosse. meanwhile, calling out the pay czar they call executive pay for companies bailed out by the government, including gm, insurer aig and allied financial. >>> and we've all heard that chicken wings are more expensive this year, but come on, a chicken wing black market? two georgia men were arrested for allegedly stealing $65,000 of tyson frozen chicken wings
will report to you. miss su comes to us from pfizer in new york city where
. pfizer was a blue chip winner. the stock jumped 3% as the drug maker's profits quadrupled, despite competition from generic forms of lipitor. the company also plans to sell its nutrition to nestle for $4.8 billion. if you're a first-class flyer you might want to consider a step up to a private jet. startup firm black jet is borrowing the big airline adage that an empty seat is a money loser. so, it charters private jets that would otherwise remain empty and sells individual seats. what's more, you can book your seat through a smartphone app. still to come, test your negotiation skills behind the wheel. how to talk down the price of a new car. that's later. but first, ahead of facebook's earnings, we'll see what it takes to be a zuckerberg in the world of business. that's next with bill moller. he has had some missteps, but you can't deny mark zuckerberg is a sharp business person. so's the woman who has written a fascinating book called "think like zuck: the five business secrets of facebook's improbably brilliant ceo mark zuckerberg." ekaterina walter is "social innovator" at int
're on. drug makers, pfizer at a new 52-week high. up 1.4%. biogen idec, bristol-meyers, eli little i. bristol-myers beat the street with fourth quarter earnings. biogen idec receiving positive clinical trial results for their drugs. bristol-myers reaching an agreement, $80 million in order to settle claims for injured child drug problems. the bank index. you're seeing lots of winners there. the vix, the fear index actually above that 1 mark again. but still sitting above 1,808. this is fifth grade charter school from brooklyn. future investors of america. [shouting] melissa: future broadcasters, maybe. very cute. nicole, thanks so much. lori: what is fun thing to do on this otherwise frigid day in new york city. all fair's in love and hair? next we tell you where men and women can pay the same price for a trip to the salon. melissa: j.c. penney's's pricing strategy take two. will customers embrace this new plan? ♪ . twins. i didn't see them coming. i have obligations. cute obligations, but obligations. i need to rethink the core of my portfolio. what i really need is sleep. introdu
of 14,000. eight components hit new highs today. beyond the five on your screen, utx, pfizer and p & g also doing it. now, speaking of history, historically life is good, larry, as you well know when the dow transports show leadership, up another 3% for the week. apple used to be leadership but not right now. the stock hitting a 52-week low and has lost the distinction of being the world's most profitable company, exxon back on top. and there's netflix, huge story in the other direction, even before earnings boosted shares on wednesday, the stock has been an absolute monster in 2013, up another 15% today. larry, 83% year to date. we're not even a month in, okay? that's unbelievable. a quick note looking ahead, more than a hundred companies in the s&p report next week, a few of the most interesting ones, at least to me, caterpillar and yahoo! monday, amazon tuesday, facebook wednesday and exxon/mobil on friday. 270 points and an all-time high on the dow. >> medium cap, midcap and small cap indexes are outperforming the big cap indexes, which gives everything, i think, some real bolsteri
the pharmaceutical companies as growth entities. decent multiples from pfizer, j and j, merck. now they are getting back to where they were. so let's ponder these apple to apple comparisons. pfizer should have $20 billion this year. j and j. merck which remember isn't back yet nearly to where it was, has $12 billion in cash flow. i'm amazed at how cheap these drug stocks are on those cash multiples. consider that at&t, the original seller of the apple iphone is down 18 points. and verizon is barely up from that despite increases from both companies. how about the stars since the 2007 peak? aren't they due for a fall? since we were last at these exalted heights home depot at gone from 41 to 67. in the interim, it has distanced itself and it is still inexpensive on earnings. same with ibm. it has come up to $204. but the company earnings have almost doubled but they are forecasting $20 a share. doable number. the stock is not cheap. in the near term maybe, but on a 2015 basis, very inexpensive. does disney belong at 54, up from 34? the stock deserves this improvement. in fact, i can say there are ple
Search Results 0 to 49 of about 116 (some duplicates have been removed)